Apotheek VAN Backlé SPRL

Apotheek VAN Backlé reported total assets of 790,697 € at the end of the 2024 financial year (annual accounts filed with the NBB on 03 Nov 2025).

Company number (CBE) 0832.429.848 · VAT BE0832429848
1780 Wemmel
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 04 Jan 2011 (≈ 15 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek VAN Backlé shows with a free account.

See the score
Profile
SPRL since 2011
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2024

Net result−8,300 €
Equity217,442 €
Cash97,819 €
EBITDA84,159 €
Total assets790,697 €
Solvency27.5%
The line marks its sector median: 44.2% (2068 companies).

Change 2021 → 2024: Equity +577 % Total assets +78 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek VAN Backlé's annual accounts

20242023202220212020
Net result−8,300 €
Equity217,442 €
Cash97,819 €
EBITDA84,159 €
Total assets790,697 €

Filed annual accounts

  • Year ended 31 Dec 2024filed on 03 Nov 2025
  • Year ended 31 Dec 2023filed on 23 Dec 2024
  • Year ended 31 Dec 2022filed on 22 Oct 2023
  • Year ended 31 Dec 2021filed on 17 Aug 2022
  • Year ended 31 Dec 2020filed on 28 Jun 2021

Apotheek VAN Backlé's financial analysis

Management and control of Apotheek VAN Backlé

1 active director(s) in the register.

Apotheek VAN Backlé's shareholders and holdings →

Apotheek VAN Backlé's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0832.429.848
VAT number
BE0832429848
Peppol
Registered · 0208:0832429848 · as of 10 Nov 2026
Legal form
SPRL
Incorporated
04 Jan 2011
Registered office
1780 Wemmel
Latest accounts
2024 · filed on 03 Nov 2025
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek VAN Backlé (SPRL) has been based in Wemmel since 2011, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 8,300 € and equity of 217,442 €; its revenue is not published. Its solvency stands at 27.5%, below the median of its sector (44.2%).

Companies similar to Apotheek VAN Backlé

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek VAN Backlé

What is the revenue of Apotheek VAN Backlé?

Apotheek VAN Backlé files its accounts in a format where revenue is optional: it is not published for 2024.

What is the VAT number of Apotheek VAN Backlé?

In Belgium, the VAT number is the company number prefixed with BE: BE0832429848 for Apotheek VAN Backlé, if the company is VAT-registered. Its company number (CBE) is 0832.429.848.

Where is the registered office of Apotheek VAN Backlé?

According to the CBE register, the registered office of Apotheek VAN Backlé is in 1780 Wemmel.

What is the equity of Apotheek VAN Backlé?

At the close of the 2024 financial year, the equity of Apotheek VAN Backlé amounts to 217,442 €, a solvency of 27.5% of total assets.

Who manages Apotheek VAN Backlé?

The register lists 1 active mandates at Apotheek VAN Backlé. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek VAN Backlé

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 09 Aug 2026

No credit card, no commitment.

What each plan unlocks →